Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines
- PMID: 2898476
- PMCID: PMC12243764
- DOI: 10.1007/BF00405839
Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines
Abstract
The antiproliferative effect of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines (CG5, T 47 D, and ZR 75-1) is reported. Both peptides markedly inhibited CG5 cell growth with a maximal inhibition of about 40% as compared with control cells. The antiproliferative effect of somatostatin on T 47 D and ZR 75-1 cells was much less evident. These results suggest that somatostatin is a peptide inhibitory factor for human breast cancer cells. Possible therapeutic implications of these findings are still to be investigated.
References
-
- Del Pozo E, Nenfeld M, Schluter K, Tortora F, Clarenbach P, Bieder E, Wendel L, Nuesch A, Marbach P, Cramer M, Kerp L (1986) Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. Acta Endocrinol 11:433–439 - PubMed
-
- Fockens JA, Henkelman MS, Furkkink JF, Blankestein MA, Klijn JGM (1986) Combined effects of buserelin estradiol and tamoxifen on the growth of MCF-7 human breast cancer cells in vitro. Biochem Biophys Res Commun 140:550–556 - PubMed
-
- Ghirlanda G, Uccioli L, Perri F, Altomonte L, Bertoli A, Manna R, Frati L, Greco AV (1983) Epidermal growth factor, somatostatin and psoriasis. Lancet I:65 - PubMed
-
- Hierowski MT, Liebow C, Du Sapin K, Schally AV (1985) Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA Pa Ca-2 cell line. FEBS Lett 179:252–256 - PubMed
-
- Iversen OH (1981) The chalones. In: Baserga R (ed) Tissue growth factors. Springer, Berlin Heidelberg New York, pp 491–503
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical